ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, January 30, 2015, to discuss ImmunoGen’s financial results for the three-month period ended December 31, 2014, the second quarter of its 2015 fiscal year. Management will also provide an update on the Company.
Help employers find you! Check out all the jobs and post your resume.
